Skip to content

The application of remimazolam tosilate in elderly patients undergoing hip joint surgery

The application of remimazolam tosilate in elderly patients undergoing hip joint surgery

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071696
Enrollment
Unknown
Registered
2023-05-23
Start date
2023-05-10
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hip joint surgery

Interventions

Remimazolam tosilate group:Use remimazolam tosilate during anesthesia induction
Propofol group :Use propofol during anesthesia induction

Sponsors

Sichuan province orthopaedic hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Patients aged over 65 years old; (2) Scheduled to undergo total hip replacement surgery under general anesthesia; (3) Obtain informed consent from patients or their family members

Exclusion criteria

Exclusion criteria: (1) Patients who are allergic to remimazolam tosilate or patients who have severe allergic history and family history in the past; (2)Dementia (including dementia with Parkinson's disease,Alzheimer's disease and Lewy bodies); (3) Had a history of stroke or any other central nervous system disease within 6 months; (4) Inability to communicate because of severe visual, auditory or verbal problems; (5) Patients with severe respiratory or cardiovascular diseases; (6) Patients with severe liver and kidney dysfunction; (7) Patients considered unfit to participate in this clinical study

Design outcomes

Primary

MeasureTime frame
Mean arterial pressure; Systolic blood pressure;heart rate;Cardiac index;bispect ral index;

Secondary

MeasureTime frame
Dosage of vasoactive drugs;CAM-ICU score;RASS score;VAS score;Incidence of injection pain;Incidence of postoperative nausea and vomiting;

Countries

China

Contacts

Public ContactPeiyu Li

Sichuan province orthopaedic hospital

65223091@qq.com+86 182 1552 6780

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026